Safety and Efficacy of Doravirine, Tenofovir, Lamivudine (MK-1439A) in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)
Clinical trial NCT02629822 · COMPLETED
Trial details
- NCT number
- NCT02629822
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-14
- Primary completion
- 2018-11-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.